80 related articles for article (PubMed ID: 10896028)
1. Relationship between cocaine-induced hepatotoxic neurobehavioral & biochemical changes in mice: the antidotal effects of buprenorphine.
Hayase T; Yamamoto Y; Yamamoto K; Abiru H; Nishitani Y; Fukui Y
Life Sci; 2000 May; 67(1):45-52. PubMed ID: 10896028
[TBL] [Abstract][Full Text] [Related]
2. Antidotal effects of buprenorphine on the behavioral alterations accompanying cocaine and combined cocaine-ethanol toxicity.
Hayase T; Yamamoto Y; Yamamoto K
Pharmacol Biochem Behav; 2002; 71(1-2):19-27. PubMed ID: 11812504
[TBL] [Abstract][Full Text] [Related]
3. Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs.
Hayase T; Yamamoto Y; Yamamoto K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Dec; 35(6):402-14. PubMed ID: 11197874
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of buprenorphine against amplified cocaine and ethanol lethality in mice: role of cocaethylene.
Hayase T; Yamamoto Y; Yamamoto K
J Toxicol Sci; 1996 May; 21(2):143-56. PubMed ID: 8780998
[TBL] [Abstract][Full Text] [Related]
5. Microarray profile analysis of toxic cocaine-induced alterations in the expression of mouse brain gene sequences: a possible 'protective' effect of buprenorphine.
Hayase T; Yamamoto Y; Yamamoto K; Muso E; Shiota K
J Appl Toxicol; 2004; 24(1):15-20. PubMed ID: 14745842
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
[TBL] [Abstract][Full Text] [Related]
7. Effects of ethanol and/or cardiovascular drugs on cocaine- and methamphetamine-induced fatal toxicities in mice.
Hayase T; Yamamoto Y; Yamamoto K; Abiru H; Nishitani Y; Fukui Y
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Oct; 34(5):475-90. PubMed ID: 10565158
[TBL] [Abstract][Full Text] [Related]
8. Hepatic glutathione and hepatotoxicity: changes induced by selected narcotics.
James RC; Goodman DR; Harbison RD
J Pharmacol Exp Ther; 1982 Jun; 221(3):708-14. PubMed ID: 7086683
[TBL] [Abstract][Full Text] [Related]
9. Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study.
Mustafa HN; El Awdan SA; Hegazy GA
Tissue Cell; 2013 Oct; 45(5):350-62. PubMed ID: 23876406
[TBL] [Abstract][Full Text] [Related]
10. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine.
Ndikum-Moffor FM; Schoeb TR; Roberts SM
J Pharmacol Exp Ther; 1998 Jan; 284(1):413-9. PubMed ID: 9435205
[TBL] [Abstract][Full Text] [Related]
11. Effects of buprenorphine and Ro 15-4513 on delayed death and brain beta-endorphin levels in rats treated with cocaine or cocaine-ethanol.
Hayase T; Yamamoto Y; Yamamoto K; Abiru H; Fukui Y
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Apr; 33(2):112-34. PubMed ID: 9613100
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.
Sarhan S; Knödgen B; Grauffel C; Seiler N
Neurochem Res; 1993 Apr; 18(4):539-49. PubMed ID: 8474573
[TBL] [Abstract][Full Text] [Related]
13. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
Yurdaydin C; Li Y; Ha JH; Jones EA; Rothman R; Basile AS
J Pharmacol Exp Ther; 1995 Apr; 273(1):185-92. PubMed ID: 7714765
[TBL] [Abstract][Full Text] [Related]
14. Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats.
El-Marasy SA; El Awdan SA; Abd-Elsalam RM
Chem Biol Interact; 2019 Feb; 299():111-119. PubMed ID: 30500344
[TBL] [Abstract][Full Text] [Related]
15. Pravastatin for thioacetamide-induced hepatic failure and encephalopathy.
Huang HC; Chang CC; Wang SS; Chan CY; Lee FY; Chuang CL; Hsin IF; Teng TH; Lin HC; Lee SD
Eur J Clin Invest; 2012 Feb; 42(2):139-45. PubMed ID: 21749370
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity.
Hayase T; Yamamoto Y; Yamamoto K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Dec; 36(6):596-608. PubMed ID: 11828716
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and electroencephalographic manifestations of thioacetamide-induced encephalopathy in rats.
Mladenović D; Radosavljević T; Hrnčić D; Rašić-Marković A; Puškaš N; Maksić N; Djuric D; Stanojlović O
Can J Physiol Pharmacol; 2012 Sep; 90(9):1219-27. PubMed ID: 22913436
[TBL] [Abstract][Full Text] [Related]
18. A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice: a behavioral and neurochemical study.
Miranda AS; Rodrigues DH; Vieira LB; Lima CX; Rachid MA; Vidigal PV; Gomez MV; Reis HJ; Guatimosim C; Teixeira AL
Arq Neuropsiquiatr; 2010 Aug; 68(4):597-602. PubMed ID: 20730316
[TBL] [Abstract][Full Text] [Related]
19. Prenatal administration of buprenorphine using the osmotic minipump: a preliminary study of maternal and offspring toxicity and growth in the rat.
Hutchings DE; Zmitrovich AC; Hamowy AS; Liu PY
Neurotoxicol Teratol; 1995; 17(4):419-23. PubMed ID: 7565488
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity.
Bornheim LM
Toxicol Appl Pharmacol; 1998 May; 150(1):158-65. PubMed ID: 9630465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
